New Phase 1 Study for Becker Muscular Dystrophy Treatment
source: pixabay.com

New Phase 1 Study for Becker Muscular Dystrophy Treatment

Edgewise Therapeutics has announced their plan to initiate a Phase 1 trial of EDG-5506, their small molecule therapy for Becker muscular dystrophy. It will take place at Worldwide Clinical Trials…

Continue Reading New Phase 1 Study for Becker Muscular Dystrophy Treatment

COVID-19 Advice for Patients with Becker or Duchenne Muscular Dystrophy

With 4.15 million cases across the globe, COVID-19 is at the forefront of discussion. Knowledge about the viral pandemic continues to grow each and every day. Yet there are still…

Continue Reading COVID-19 Advice for Patients with Becker or Duchenne Muscular Dystrophy

The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment

The Cure Rare Disease Foundation The Cure Rare Disease Foundation's mission is to increase collaborative efforts between researchers in order to accelerate the development of customized therapies for individuals living with…

Continue Reading The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment
Close Menu